Healthcare Triangle, Inc. (Nasdaq: HCTI), a prominent provider of digital transformation solutions for the healthcare and life sciences sectors, has announced a 1-for-249 reverse stock split of its common stock. This strategic decision, effective from August 1, 2025, aims to elevate the company's stock price to comply with the Nasdaq Capital Market's $1.00 minimum bid price requirement. The adjustment will convert every 249 shares into one, significantly reducing the number of outstanding shares from approximately 1.5 billion to about 5.8 million.
The reverse stock split, approved by stockholders in a special meeting on February 26, 2025, is a critical step for Healthcare Triangle to maintain its listing on Nasdaq. This move is expected to enhance the stock's marketability and appeal to a broader range of investors by increasing the per-share price without altering the total market capitalization. Stockholders will receive detailed information about their adjusted share holdings from VStock Transfer, LLC, the company's transfer agent.
For further details, investors can refer to the definitive information statement on Schedule 14C filed with the U.S. Securities and Exchange Commission on March 17, 2025, available at https://sec.gov. This development underscores the company's commitment to regulatory compliance and its strategic efforts to strengthen its financial standing in the competitive healthcare technology market.
